pharmaphorum October 5, 2023
Phil Taylor

A digital health application (DiGA) has been shown to relieve the distress that patients can experience when managing diabetes, which can compromise their care, in a randomised clinical trial.

Diabetes distress is an emotional reaction specific to the demands of diabetes and diabetes therapy – leading to feelings of hopelessness, discouragement and exhaustion – which is not necessarily pathological, but can become so if present at an elevated level, according to study investigator Dominic Ehrmann of the FIDAM diabetes research institute in Germany.

He told the EASD meeting this week that it is clinically relevant to monitor diabetes distress, as high levels have been linked to a risk of depression, poorer quality-of-life, and suboptimal management of diabetes that can worsen...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Apps, Biotechnology, Clinical Trials, Digital Health, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Technology, Trends
Medicare insurers ranked by mobile app quality
How an App Store Approach Fuels Innovation and Efficiency in Healthcare
'The generation that created the internet is now our audience': SCAN Group prepares to launch first mobile app
Apple’s Vision Pro has a problem a year into its existence: Not enough apps
Research reveals concerning links between fitness apps and disordered eating

Share This Article